# Pyxis Oncology, Inc.: Form 8-K, filed Oct 1, 2026

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: 8-K
- Filed: 2026-10-01
- Accepted by EDGAR: Oct 1, 2026, 17:24 ET
- Period: 2026-09-29
- Accession: 0001437749-26-031767
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000143774926031767/pyxs20261001_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000143774926031767/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000143774926031767/pyxs20261001_8k.htm

Filed Oct 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-031767. Last ingested by Listed: Nov 6, 2026, 18:47 ET. No prices; not investment advice.